O'Shaughnessy Asset Management, LLC Repligen Corp Transaction History

O'Shaughnessy Asset Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $21,347 - $26,052	125 Added 6.95%	1,924 $353,000
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $71,127 - $115,473	-623 Reduced 25.72%	1,799 $323,000
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $336,125 - $427,507	2,422 New	2,422 $385,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $246,244 - $393,282	1,535 New	1,535 $287,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $160,706 - $257,186	-997 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $7,922 - $9,743	-32 Reduced 3.11%	997 $264,000
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $59,599 - $99,208	306 Added 42.32%	1,029 $298,000
Q2 2021 Aug 09, 2021	BUY	$165.87 - $220.95 $33,505 - $44,631	202 Added 38.77%	723 $144,000
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $1,803 - $2,262	-10 Reduced 1.88%	521 $101,000
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $71,966 - $100,393	486 Added 1080.0%	531 $102,000
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $798,397 - $1.03 Million	-6,517 Reduced 99.31%	45 $7,000
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $21,601 - $32,169	-229 Reduced 3.37%	6,562 $812,000
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $562,690 - $722,834	-6,623 Reduced 49.37%	6,791 $658,000
Q4 2019 Feb 12, 2020	SELL	$73.84 - $93.08 $101,677 - $128,171	-1,377 Reduced 9.31%	13,414 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $595,263 - $741,730	7,766 Added 110.55%	14,791 $1.13 Million
Q1 2019 May 10, 2019	BUY	$49.45 - $62.8 $347,386 - $441,170	7,025 New	7,025 $0

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.